HCPCS A9542 — In111 ibritumomab, dx (2026 RVU Values)

HCPCS code A9542 (In111 ibritumomab, dx) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.

Related references